Perceptions of acceptance and reluctance to COVID-19 vaccination in Peru


  • Janeth Tenorio-Mucha CONEVID, Unidad de Conocimiento y Evidencia, Facultad de Medicina «Alberto Hurtado», Universidad Peruana Cayetano Heredia, Lima, Perú; CRONICAS Centro de Excelencia en Enfermedades Crónicas, Universidad Peruana Cayetano Heredia, Lima, Perú
  • Jill Portocarrero CRONICAS Centro de Excelencia en Enfermedades Crónicas, Universidad Peruana Cayetano Heredia, Lima, Perú
  • Patricia Busta-Flores CONEVID, Unidad de Conocimiento y Evidencia, Facultad de Medicina «Alberto Hurtado», Universidad Peruana Cayetano Heredia, Lima, Perú
  • M. Amalia Pesantes CRONICAS Centro de Excelencia en Enfermedades Crónicas, Universidad Peruana Cayetano Heredia, Lima, Perú; Dickinson College, Pennsylvania, United States of America
  • María Lazo-Porras CONEVID, Unidad de Conocimiento y Evidencia, Facultad de Medicina «Alberto Hurtado», Universidad Peruana Cayetano Heredia, Lima, Perú; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals & University of Geneva, Geneva, Switzerland



COVID-19, COVID-19 vaccines, Vaccination Refusal, Health Belief Model


Objectives. To explore factors that influence the acceptance or reluctance to COVID-19 vaccination using qualitative methods. Materials and methods. Descriptive qualitative study conducted between April and June 2021. A semi-structured interview guide was used to explore the perceptions of participants from different regions of Peru regarding COVID-19 vaccination. The Health Belief Model was used as theoretical framework and its dimensions are: susceptibility, severity, benefits, barriers, and cues to action. Results. We interviewed 30 people, mostly were women. For the participants, the efficacy of vaccines is related to the country of origin of the vaccines; in addition, they consider that it is important to know the long-term effects on health after vaccination. The information received by governmental and health authorities can be a decisive factor for vaccination. People with the intention of not being vaccinated feel that vaccination promotion strategies violate their human rights. Conclusions. There is a group of people undecided or unsure about receiving COVID-19 vaccines who need to be encouraged according to their concerns and needs. Governmental and health authorities should work together to improve the confidence of the population and provide messages to clarify doubts about the efficacy and adverse reactions of vaccines.


Download data is not yet available.


Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. 382(21):1969–73. doi: 10.1056/NEJMP2005630.

Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, Exel J van, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Heal Econ. 21(7):977. doi: 10.1007/S10198-020-01208-6.

Lazarus JV., Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 27(2):225–8. doi: 10.1038/s41591-020-1124-9.

Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults. Ann Intern Med. doi: 10.7326/M20-3569.

Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong L. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis. 14(12):e0008961. doi: 10.1371/JOURNAL.PNTD.0008961.

Jones CL, Jensen JD, Scherr CL, Brown NR, Christy K, Weaver J. The Health Belief Model as an Explanatory Framework in Communication Research: Exploring Parallel, Serial, and Moderated Mediation. Health Commun. 30(6):566–76. doi: 10.1080/10410236.2013.873363.

Drug USF and FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine | FDA [Internet]. Disponible en:

Vacuna contra el covid-19: Reino Unido se convierte en el primer país del mundo en aprobar la vacuna de Pfizer/BioNTech - BBC News Mundo [Internet]. Disponible en:

Cronología: Rastreando el camino hacia la vacunación en América Latina | AS/COA [Internet]. Disponible en:

Documento técnico: Plan Nacional actualizado de vacunación contra la COVID-19 [Internet]. Disponible en: Nacional Actualizado contra la COVID-19.pdf.

MINSA: el lunes 8 de marzo se iniciará vacunación contra COVID-19 para adultos mayores [Internet]. Disponible en:

Al-Jayyousi GF, Sherbash MAM, Ali LAM, El-Heneidy A, Alhussaini NWZ, Elhassan MEA, et al. Factors Influencing Public Attitudes towards COVID-19 Vaccination: A Scoping Review Informed by the Socio-Ecological Model. Vaccines. 9(6). doi: 10.3390/VACCINES9060548.

Nehal KR, Steendam LM, Ponce MC, Hoeven M van der, Smit GSA. Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis. Vaccines. 9(10):1071. doi:10.3390/VACCINES9101071.

Johns Hopkins University. Mortality Analyses - Johns Hopkins Coronavirus Resource Center [Internet]. 2022. Disponible en:

Diario Oficial El Peruano. Decreto Supremo - N° 044-2020-PCM. DS N° 044-2020-PCM. Diario Oficial El Peruano. 2020.

Lossio J. Covid-19 en el Perú: respuestas estatales y sociales. História, Ciências, Saúde-Manguinhos. 28(2):581–5. doi: 10.1590/S0104-59702021005000001.

Chauvin L. Peruvian COVID-19 vaccine scandal spreads. Lancet. 397(10276):783. doi: 10.1016/S0140-6736(21)00508-0.

Champion VL, Skinner CS. The health belief model. Heal Behav Heal Educ Theory Res Pract. 4:45–65.

Coe A, Gatewood S, Moczygemba L, Goode J, Beckner J. The use of the health belief model to assess predictors of intent to receive the novel (2009) H1N1 influenza vaccine. Inov Pharm. 3(2). doi: 10.24926/IIP.V3I2.257.

Banik R, Islam MS, Pranta MUR, Rahman QM, Rahman M, Pardhan S, et al. Understanding the determinants of COVID-19 vaccination intention and willingness to pay: findings from a population-based survey in Bangladesh. BMC Infect Dis. 2021 211. 21(1):1–15. doi: 10.1186/S12879-021-06406-Y.

Ping Wong L, Alias H, Wong PF, Yen Lee H, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. doi: 10.1080/21645515.2020.1790279.

Creswell JW, Creswell JD. Research design: qualitative, quantitative, and mixed methods approaches. 5 ed. editio. Science S, editor. United States: SAGE Publications; 2017. 304 p.

Gubrium JF, Holstein JA, Marvasti A, McKinney KD. The SAGE Handbook of interview research. The complexity of the Craft. 2ed. editio. SAGE Publications; 2012. 624 p.

Ministerio de Salud. Sala de Situacion de Covid [Internet]. Disponible en:

Lockyer B, Islam SA, Rahman A, Dickerson J, Pickett K, Sheldon T, et al. Understanding COVID-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK. Health Expect. 24(4):1158–67. doi: 10.1111/HEX.13240.

Lin C, Tu P, Beitsch LM. Confidence and receptivity for covid‐19 vaccines: A rapid systematic review. Vol. 9, Vaccines. MDPI AG; 2021. p. 1–32. doi: 10.3390/vaccines9010016.

Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 39(7):1148–56. doi: 10.1016/J.VACCINE.2020.12.083.

Archibald MM, Ambagtsheer RC, Casey MG, Lawless M. Using Zoom Videoconferencing for Qualitative Data Collection: Perceptions and Experiences of Researchers and Participants: Int J Qual Methods. 18:1–8. doi: 10.1177/1609406919874596.

Keen S, Lomeli-Rodriguez M, Joffe H. From Challenge to Opportunity: Virtual Qualitative Research During COVID-19 and Beyond. Int J Qual Methods. 21:160940692211050. doi: 10.1177/16094069221105075.

Booth A, Hannes K, Harden A, Noyes J, Harris J, Tong A. COREQ (Consolidated Criteria for Reporting Qualitative Studies). Guidel Report Heal

Res A User’s Man. :214–26. doi: 10.1002/9781118715598.CH21.

Enkel SL, Attwell K, Snelling TL, Christian HE. ‘Hesitant compliers’:

Qualitative analysis of concerned fully-vaccinating parents. Vaccine. 36(44):6459–63. doi: 10.1016/j.vaccine.2017.09.088.

WHO technical advisory group on behavioural insight and sciences for

health. Behavioural considerations for acceptance and uptake of COVID-19 vaccines. Geneva; 2020.

Mahroum N, Lavine N, Ohayon A, Seida R, Alwani A, Alrais M, et al. COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review. Front Immunol. 13:1. doi: 10.3389/FIMMU.2022.872683.

Ehde D, Roberts M, Humbert A, Herring T, Alschuler K. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021. Mult Scler Relat Disord. 54(103163). doi: 10.1016/J.MSARD.2021.103163.

Government of the United Kingdom. Factors influencing COVID-19 vaccine uptake among minority ethnic groups, 17 December 2020 - GOV.UK

[Internet]. 2021. p. 15. Disponible en:

Hoppe KK, Eckert LO. Achieving High Coverage of H1N1 Influenza Vaccine in an Ethnically Diverse Obstetric Population: Success of a Multifaceted Approach. Infect Dis Obstet Gynecol. 2011. doi: 10.1155/2011/746214.

Frank LB, Murphy ST, Chatterjee JS, Moran MB, Baezconde-Garbanati L.

Telling Stories, Saving Lives: Creating Narrative Health Messages. Health Commun. 30(2):154. doi: 10.1080/10410236.2014.974126.





Original Article

How to Cite

Tenorio-Mucha J, Portocarrero J, Busta-Flores P, Pesantes MA, Lazo-Porras M. Perceptions of acceptance and reluctance to COVID-19 vaccination in Peru. Rev Peru Med Exp Salud Publica [Internet]. 2022 Sep. 30 [cited 2024 Apr. 16];39(3):274-80. Available from:

Most read articles by the same author(s)